Zebrain is the Nordics’ first platform for people development powered by coaching! A digital, efficient and measurable methodology that creates success for individuals, teams and entire organisations. ICF-certified coaches ensure that our clients receive the best support based on individual needs and goals. Our unique algorithms match every user with the right coach just for them, to create accuracy in both behavioural styles, chemistry, knowledge and needs. By digitalising coaching, we are making personal development accessible for everyone, regardless of time and place. Our solutions: Executive and Managament coaching Leadership and Team Coaching Health and Stress Coaching Motivation and Performance Career Development Outplacement We are convinced that everyone should have the right to personal development! Read more at https://www.zebrain.se/sv/

MDSI are working on innovative new products, which we believe will fill a gap within the Defence Industry. Our mission is to combine military operational experience with rapid innovation to deliver innovative solutions to a market that is traditionally slow moving. MDSI currently consists of 25 dedicated employees, including 8 engineers, and we expect to add 10-15 new employees to our team within the next year.

In VISCAN, we provide 3D capture services and use multiple software to create interactive and immersive Digital Twins of the buildings. We help property owners and managers to make their communication and operational processes more efficient, more effective, and more sustainable. Our services can help businesses to optimize costs and carbon footprint, as well as improve onboarding, planning, marketing, and maintenance activities. We believe that by 2025 property presentations with only steel photography will be as popular as CDs today, and virtual reality devices will be as common as smartphones now. We are part of that shift, and we want to help in property digitalization not only in Norway but also in other Scandinavian countries. Metaverse needs digital assets and we help in creating them. Join us!

Ditt neste eventyr starter her Rebil er et nytt bruktbilkonsept, hvor kundene får sin nye bruktbil levert hjem på døren med noen få klikk på nett. Rebils ambisjon er å gjøre bruktbil enkelt og trygt med en sømløs kundereise. Etter en pangstart fra lansering sist år er vi nå klare for å gire opp. Vi vokser kraftig og mulighetene hos oss er mange for deg med et ønske om å utfordre det etablerte!Om Rebil Rebil er en ny og annerledes aktør innen bruktbil. Alle våre kunder kan bestille sin nye bruktbil på nett og få den raskt levert på døren. Kunden får:  Gratis levering: Bilen levert hjem helt gratis innen 24 timer Åpent kjøp: 14 dager åpent kjøp og alle pengene tilbake hvis de ombestemmer seg  Ingen overraskelser: Grundig tilstandssjekk, komplett service og minimum 6 mnd garanti Bilene som kjøpes inn blir nøye inspisert og istandsatt, hvor vi til og med viser evt. gjenværende bruksmerker til kunden for fullstendig åpenhet. Bak Rebil står Askeladden & Co. Askeladden starter og skalerer selskaper, og står bak selskaper som legeklinikken Dr. Dropin, massasjekjeden Squeeze, tannlegeklinikken Blid, pizzakjeden Digg og mange flere.

We have produced a unique app for fishing (so far in saltwater, Norway). After 6 weeks, we have been downloaded 85.000 times, in Norway. We combine the knowledge of the best fishermen in the country with AI, being a unique app for all types of fishing people. We combine 50 years of knowledge with cutting-edge technology, making the best fishing-app for everyone wanting to go fishing!

Tipio en markedsplass for gruppekjøp som gir forbrukere de beste dealene på kjente produkter og tjenester. Vi endrer markedsdynamikken som kun er drevet av push, hvor forbrukerne endelig kan være med å påvirke og engasjere seg i en toveis dialog med marked. På den andre siden taper bedrifter over 80 milliarder dollar bare i år på de strenge reglene for GPDR/personvern og at ca 50% skrur av all sporings muligheter. Bransjen er i en enorm omstilling og er desperate etter alternative løsninger som hjelper de med dette. Det er her Tipio kommer inn å bidrar med økt salg, senke risikoen knyttet til markedsføring og tilbyr unike datainnsikter slik at bedriftene kan sende relevant og engasjerende budskap til dens kunder så markedet kan vinne sammen.

Med-Storm's Skin Conductance Algesimeter (SCA) uses the principle of skin conductance to measure pain, allowing us to titrate the right amount of pain medication for each, individual patient. This award-winning technology is not affected by changes in blood circulation, heart rate, hypotensia, environmental temperatures, and hypoxia, and shows low variation between individuals at the same level of pain. The pain monitor can be used on patients as young as 23 weeks of gestational age, as well as geriatric patients. MS is currently working on a miniaturized and wireless version of the SCA.

Disruptive Engineering enables more effective planning, management, and monitoring of road networks. Proprietary sensor hardware 'made in Norway'Use AI and neural networks for detailed classification of vehicles. Privacy-by-design solution ensuring that no personal data is stored or shared. With traffic expected to grow by 60% by 2050, and with congestion and safety already being an issue, there is a pressing need to utilize road networks more efficiently. Both Statens Vegvesen and Nye Veier see our first sensor VS1, and the valuable data it provides, as a potential solution to achieve this as well as an opportunity to digitalize roads and infrastructure for the forthcoming Intelligent Transportation Systems (ITS) that are being implemented across Europe.Statens Vegvesen linkNye Veier link

UNISOT is a young Norwegian start-up company and is the first global Blockchain solution based on tight integration with Enterprise Resource Planning (ERP) systems, such as SAP and other major ERP and SCM systems. Its permissionless manner will allow unprecedented abilities for secure information exchange and secure information storage to companies and/or organizations all over the world. For the first time and with the help of the open, public blockchain, UNISOT can now offer access to a reliable and secure “Universal Source of Truth” that all parties can use to handle the challenges in today’s supply chain environment, such as increased globalization, faster pace of change, global traceability, information shortage, and settlement costs, to name a few. UNISOT is leveraging the very well-established ERP Business Processes with the trust, security, immutability, and tokenization that the Open Public Permissionless Blockchain technology provides.

Klarna offer smoooth payments to 130.000 webshops and retailers across the globe. The company has 2500 employees spread over our 14 markets. Klarna Checkout is the main product, which offers merchants 1 integration, 1 agreement, 1 settlement for handling payments online and in stores. Klarna Norway AS has 15 (and increasing) employees who work at the 26th floor at Posthuset in Oslo.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Fishency Innovation can give access to the entire salmon industry to affordable equipment to count automatically sea lice in the cage. Monitoring sea lice is the key to controlling them, it is access to good decision support for optimized treatments and to a reliable tool to measure the efficiency of preventive measures and existing treatments. Today, sea lice are counted manually over 20 fish, every week, in each cage. It is labor-demanding, and the collected data are not reliable. Sustainability starts with good data.

Evoltec (Evolution Technologies) is a Norwegian-based technological integrated service Company, established in January 2015. We are an evolving technological services and products provider with a focus on the marine and energy industry, In particular within the oil and gas sector. We realize and value our customer`s business needs and build cost-effective yet time-bound solutions to meet specific requirements. Our network of qualified personnel and product suppliers is capable of delivering services and products all over the world.

Antibiotic resistance and bacterial infections are a large threat to modern healthcare. The Norwegian company SoftOx Solutions has developed a patented technology with the potential of becoming a game changer in fighting infections. To achieve this SoftOx has a highly competent organization and established a long-term relationship with leading scientists from the University of Copenhagen and Excite International, Canada. SoftOx wound cleansing solution shall become the first antiseptic with solid clinical evidence of infection removal in chronic wounds, giving us a unique market position in a 90 billion NOK wound care market.

A bio-and medtech Company developing and selling proprietary solutions for using oxygen in various applications. Currently focussing on beverages (water, sports- and isotonic drinks), wound healing, cosmetics and fish farming. Licensing platform technology for applying oxygent to other products. Oxy Solutions is a privately held Norwegian based biotech company that has developed and patented an innovative technology for highly oxygenating liquid. Oxy Solutions'​ core business and strategy is to develop, document, IP protect, and commercialize the technology primarily within wound healing. The company has an in-house R&D facility in Norway. The company has funding from the Norwegian Research Council. Oxy Solutions is in possession of patented technology that makes it possible to greatly increase the dissolved level of oxygen in water. Tests have indicated stable levels in excess of 70 mg/l, or approximately 10 times higher than previously thought possible.